{
  "paper_metadata": {
    "pmid": "30631096",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR gene and its variants, specifically focusing on the G53A variant, its pathogenicity, and associated clinical data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": null,
      "protein_notation": "p.Gly53Ala",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": null,
        "demographics": "not specified",
        "phenotype": "oculoleptomeningeal amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The G53A TTR variant readily forms amyloid at physiological pH and exhibits cytotoxic activities.",
        "assays": [
          "cell viability assays on SH-SY5Y neuroblastoma cells"
        ]
      },
      "segregation_data": "Not explicitly mentioned.",
      "population_frequency": "Not provided.",
      "evidence_level": "Moderate evidence based on functional assays and cytotoxicity data.",
      "source_location": "Results and Discussion, paragraph discussing G53A variant.",
      "additional_notes": "The G53A variant is associated with a faster formation of cytotoxic oligomers compared to WT TTR.",
      "key_quotes": [
        "Notably, the pathogenic TTR variant readily forms amyloid at the physiological pH.",
        "The G53A oligomers appear to have similar cytotoxic activities to those of WT TTR oligomers."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction focused solely on the TTR gene and its variants as specified."
  }
}